Saturday March 23, 2019
Home Entertainment Film Stars st...

Film Stars step out for a Friendly Cricket Match to Raise Awareness and Funds for Cancer Patients

Cricket is something everyone plays since childhood in India. It is the biggest sport in India and to mix it with a social cause is the best thing

0
//
cricket
Rajneesh Duggal was part of the crew who played the friendly match. Wikimedia

Mumbai, October 22, 2017 : Film celebrities like Rajneesh Duggall, Zayed Khan and Saqib Saleem stepped out for a friendly cricket match to create awareness and raise funds for cancer patients.

They played as part of the Ink Cricket Blast 2017 here on Saturday.

The cause is close to Rajneesh’s heart as someone in his family is suffering from cancer.

“This is a great initiative and I am always up for a social issue. This is something which is very close to my heart. Someone in my life has been suffering from it and cancer is something I’ve always personally associated with and I feel whatever I can do from my side, I must do,” he said.

“Fukrey” fame actor Varun didn’t participate in the game, but he was there to show support.

“There is always a connection with a social cause. If you combine sports with a social cause, there is nothing better than that! Cricket is something everyone plays since childhood in India. It is the biggest sport in India and to mix it with a social cause is the best thing,” he said.

Saqib said “it’s a great cause and cricket is religion in India”.

The actor is currently finishing a film with Taapsee Pannu. It’s tentatively called “Makhna”, which will come out early next year. (IANS)

 

Next Story

Researchers Discover Balance of Two Enzymes That May Help Treat Pancreatic Cancer

While still in the earliest stages, Newton hoped this information might one day aid pancreatic diagnostics and treatment

0
Cancer
Cancer Ribbon. Pixabay

A new research has set the stage for clinicians to potentially use levels of a pancreatic cancer patient’s PHLPP1 and PKC enzymes as a prognostic and for researchers to develop new therapeutic drugs that change the balance of the two enzymes as a means to treat the disease.

The study, published on Wednesday in Molecular Cell, was led by Alexandra Newton, professor in the Department of Pharmacology at the University of California, San Diego, School of Medicine, and Timothy Baffi, a graduate student in her lab, Xinhua news agency reported.

The new study built on the team’s work in 2015 that found the enzyme PKC, which was believed in previous studies to promote tumour growth, actually suppressed it.

The latest study took the investigation a step further by uncovering how cells regulate PKC activity and discovered that any time an over-active PKC is inadvertently produced, the PHLPP1 “proofreader” tags it for destruction.

Cancer patient
Cancer patient.

“That means the amount of PHLPP1 in your cells determines your amount of PKC,” Newton said. “And it turns out those enzyme levels are especially important in pancreatic cancer.”

The team observed 105 pancreatic cancer tumours to analyze the enzyme levels in each one. About 50 per cent of patients with low PHLPP1/high PKC lived longer than five-and-a-half years.

Also Read- A Brain Circuit Can Help Reverse Craving for Liquor, Says Study

While still in the earliest stages, Newton hoped this information might one day aid pancreatic diagnostics and treatment.

Pancreatic cancer is caused by the abnormal and uncontrolled growth of cells in the pancreas, a large gland in the digestive system. It typically doesn’t show symptoms in the early stages. Sufferers tend to develop signs, such as back pain and jaundice, when it has spread to other organs. (IANS)